As of 2025-07-12, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.54) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.80 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -296.7%.
The range of the Relative Valuation is (3.10) - (4.21) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.2x - 10.7x | 9.0x |
| Forward P/E multiples | 5.1x - 9.7x | 7.4x |
| Fair Price | (3.10) - (4.21) | (3.54) |
| Upside | -272.3% - -333.9% | -296.7% |
| Date | P/E |
| 2025-07-11 | -4.16 |
| 2025-07-10 | -4.29 |
| 2025-07-09 | -4.34 |
| 2025-07-08 | -4.39 |
| 2025-07-07 | -4.55 |
| 2025-07-04 | -4.78 |
| 2025-07-03 | -4.73 |
| 2025-07-02 | -4.43 |
| 2025-06-30 | -4.27 |
| 2025-06-27 | -4.46 |
| 2025-06-26 | -4.64 |
| 2025-06-25 | -4.59 |
| 2025-06-24 | -4.25 |
| 2025-06-23 | -4.04 |
| 2025-06-20 | -3.92 |
| 2025-06-19 | -4.13 |
| 2025-06-18 | -4.13 |
| 2025-06-17 | -4.32 |
| 2025-06-16 | -4.46 |
| 2025-06-13 | -4.57 |
| 2025-06-12 | -4.50 |
| 2025-06-11 | -4.41 |
| 2025-06-10 | -4.57 |
| 2025-06-09 | -4.50 |
| 2025-06-06 | -4.43 |
| 2025-06-05 | -4.32 |
| 2025-06-04 | -4.52 |
| 2025-06-03 | -4.16 |
| 2025-06-02 | -3.92 |
| 2025-05-30 | -3.95 |
| 2025-05-29 | -3.95 |
| 2025-05-28 | -4.06 |
| 2025-05-27 | -3.69 |
| 2025-05-26 | -3.44 |
| 2025-05-23 | -3.51 |
| 2025-05-22 | -3.44 |
| 2025-05-21 | -3.39 |
| 2025-05-20 | -3.58 |
| 2025-05-16 | -3.60 |
| 2025-05-15 | -3.67 |
| 2025-05-14 | -3.58 |
| 2025-05-13 | -3.72 |
| 2025-05-12 | -3.67 |
| 2025-05-09 | -3.69 |
| 2025-05-08 | -3.67 |
| 2025-05-07 | -3.42 |
| 2025-05-06 | -3.44 |
| 2025-05-05 | -3.67 |
| 2025-05-02 | -3.65 |
| 2025-05-01 | -3.51 |